Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour registry

BJU International

Volumn 113, Issue 6, 2014, Pages 924-930

  Boustead, Gregory B ^a   Fowler, Sarah ^c   Swamy, Rajiv ^a   Kocklebergh, Roger ^b   Hounsome, Luke ^d  

^a LISTER HOSPITAL   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c BAUS Section of Oncology   (United Kingdom)

^d South West Public Health Observatory ^*  (United Kingdom)

Author keywords

bladder cancer; classification of bladder cancer; Grade; histopathology; muscle invasive bladder cancer; non muscle invasive bladder cancer; Stage; TNM classification; urothelial carcinoma of the bladder

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CHILD; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; SELECTION BIAS; SEX RATIO; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UNITED KINGDOM;

BLADDER CANCER; CLASSIFICATION OF BLADDER CANCER; GRADE; HISTOPATHOLOGY; MUSCLE-INVASIVE BLADDER CANCER; NON-MUSCLE-INVASIVE BLADDER CANCER; STAGE; TNM CLASSIFICATION; UROTHELIAL CARCINOMA OF THE BLADDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROSPECTIVE STUDIES; REGISTRIES; SOCIETIES, MEDICAL; URINARY BLADDER NEOPLASMS; UROLOGY; YOUNG ADULT;

EID: 84902293372     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12468     Document Type: Article

References (21)

1. Grasso M,. Bladder cancer: a major public health issue. Eur Urol Suppl 2008; 7: 510-515
2. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R,. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003; 21: 1315-1330
3. Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A,. Quality of life aspects of bladder cancer: a review of the literature. Qual Life Res 2003; 12: 675-688
4. Stenzl A, Hennenlotter J, Schilling D,. Can we still afford bladder cancer? Curr Opin Urol 2008; 18: 488-492
5. Brown T, Slack R, Rushton L,. Occupational cancer in Britain. Urinary tract cancers: bladder and kidney. Br J Cancer 2012; 107 (Suppl. 1): S76-84
6. Cummings KB,. Clinical versus pathologic staging and the classification of bladder cancer. Urology 1984; 23 (Suppl.): 55-62
7. Zhang HZ, Wang CF, Sun JJ, Yu BH,. A combined clinicopathologic analysis of 658 urothelial carcinoma cases of urinary bladder. Chin Med Sci J 2012; 27: 24-28
8. deVere White RW, Katz MH, Steinberg GD,. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. J Urol 2009; 181: 1994-1997
9. Matalka I, Bani-Hani K, Shotar A, Bani Hani O, Bani-Hani I,. Transitional cell carcinoma of the urinary bladder: a clinicopathological study. Singapore Med J 2008; 49: 790-794
10. NCIN. Data Quality Report 2012: Urological Cancers SSCRRG. Public Health England; 2012; Available at: http://www.ncin.org.uk/cancer-type-and-topic- specific-work/cancer-type-specific-work/urological-cancer/urological-cancer-hub/ resources. Accessed October 2013
11. Holland-Bill L, Froslev T, Friis S, et=al. Completeness of bladder cancer staging in the Danish Cancer Registry, 2004-2009. Clin Epidemiol 2012; 4 (Suppl. 2): 25-31
12. Kirkali Z, Chan T, Manoharan M, et=al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66 (Suppl. 1): 4-34
13. Rafique M, Javed AA,. Clinico-pathological features of bladder carcinoma: experience from a tertiary care hospital of Pakistan. Int Urol Nephrol 2006; 38: 247-250
14. Scosyrev E, Noyes K, Feng C, Messing E,. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009; 115: 68-74
15. Messing EM, Madeb R, Feng C, et=al. Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease. J Clin Oncol 2009; 27: 2443-2449
16. Pan CC, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DM,. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 2010; 133: 788-795
17. May M, Brookman-Amissah S, Roigas J, et=al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol 2010; 57: 850-858
18. Sauter G, Algaba F, Amin M, et=al. Tumours of the urinary system: non-invasive urothelial neoplasias. In, Eble JN, Sauter G, Epstein JI, Sesterhenn I, eds, WHO Classification of Tumours of the Urinary System and Male Genital Organs, Lyon, France: IARCC Press, 2004: 93-149
19. Hansel DE, Miller JS, Cookson MS, Chang SS,. Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist. Urology 2013; 81: 1123-1130
20. Crow P, Ritchie AW,. National and international variation in the registration of bladder cancer. BJU Int 2003; 92: 563-566
21. CRCUK. European Age-standardized Rates for Bladder Cancer, 2011. Available at: http://globocan.iarc.fr. Accessed October 2013